Physitrack PLC (STO:PTRK)
10.20
+0.78 (8.28%)
Feb 16, 2026, 1:27 PM CET
Physitrack Revenue
Physitrack had revenue of 3.46M EUR in the quarter ending September 30, 2025, a decrease of -0.24%. This brings the company's revenue in the last twelve months to 16.04M, up 13.84% year-over-year. In the year 2024, Physitrack had annual revenue of 16.18M with 9.73% growth.
Revenue (ttm)
16.04M EUR
Revenue Growth
+13.84%
P/S Ratio
0.86
Revenue / Employee
250.56K EUR
Employees
64
Market Cap
153.18M SEK
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 16.18M | 1.43M | 9.73% |
| Dec 31, 2023 | 14.75M | 2.24M | 17.87% |
| Dec 31, 2022 | 12.51M | 4.70M | 60.10% |
| Dec 31, 2021 | 7.81M | 4.76M | 155.86% |
| Nov 30, 2020 | 3.05M | 1.85M | 154.21% |
| Nov 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 34.97B |
| Swedish Orphan Biovitrum AB | 28.24B |
| Sectra AB | 3.47B |
| Camurus AB | 2.27B |
| Boule Diagnostics AB | 489.70M |
| IRLAB Therapeutics AB | 85.56M |
| Ortivus AB | 75.91M |
| Nosa Plugs AB | 17.53M |